Sirt2 Inhibition Improves Gut Epithelial Barrier Integrity and Protects Mice from Colitis

Researchers established that small-molecule inhibitors of Sirt2 were promising treatment strategies for inflammatory bowel disease. Small-molecule inhibitors of enzymes had been increasingly used to investigate the biological function of enzymes.